Claremont Biosolutions

The test detects a signature molecular marker upregulated by viable bacteria, and will be useful for pediatric, extrapulmonary, and AIDS-related TB.

The partners will couple Claremont BioSolutions' enzyme-free tissue homogenization technology with IncellDx's reagents.

NEW YORK (GenomeWeb) — A public-private team led by researchers at the Keck Graduate Institute of Life Sciences has been awarded just over $600,000 by the National Institutes of Health for the first year of a four-year project to further develop its point-of-care nucleic acid testing platform for

NEW YORK (GenomeWeb News) – Claremont BioSolutions said today it has entered a strategic partnership with investment firm In-Q-Tel to accelerate commercialization of Claremont's Prep-on-a-Chip sample preparation platform.

NEW YORK (GenomeWeb News) – Molecular diagnostics products firm Claremont BioSolutions has signed deals to distribute its products in Europe, Taiwan, and South Korea.

Claremont BioSolutions has been awarded a three-year, $3 million grant from the National Institute of Allergy and Infectious Diseases to continue developing its fully integrated and portable point-of-care assay system for detecting Clostridium difficile infections and co

Scientists from the Keck Graduate Institute of Applied Life Sciences and KGI spinout Claremont Biosolutions have been developing point-of-care molecular testing platforms and associated assays for Clostridium difficile, multi-drug-resistant tuberculosis, and herpes simpl

By a GenomeWeb staff reporter
NEW YORK (GenomeWeb News) – Claremont BioSolutions today said Funakoshi will distribute its sample preparation, DNA isolation, and protein purification products in Japan.

This article was originally published on Dec. 5.

The grants, awarded through the Qualifying Therapeutic Discovery Project Program created by the Patient Protection and Affordable Care Act of 2010, were disclosed last week by the IRS.

NPR reports that with medical data being big business, some companies want to get patients involved.

The Asbury Park Press reports on the startup Genomic Prediction's test to determine an embryo's risk of disease.

In PNAS this week: optical mapping allows glimpse of structural variants, disease-linked GATA2 mutations boosts its protein activity, and more.

Senator Elizabeth Warren (D-Mass.) has released the results of a genetic ancestry analysis, the Boston Globe reports.